The higher recurrence rate of insulinomas in MEN1 patients is primarily due to the genetic predisposition to multiple and recurrent tumors, the presence of multicentric disease, and ongoing pancreatic islet cell hyperplasia. The gene discussed is MEN1; the disease is pancreatic insulinoma.